Patents by Inventor Gregory A. Goodall

Gregory A. Goodall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC AND DIAGNOSTIC MOLECULES
    Publication number: 20180362979
    Abstract: The present invention relates to methods for modulating angiogenesis, comprising administering to a subject, or cells or tissue derived therefrom: (i) one or more miRNA, or precursors or variants thereof, wherein at least one of said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID N0:37) to inhibit angiogenesis; or (ii) one or more antagonists of a miRNA, wherein said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID N0:37) to promote or induce angiogenesis. Also provided are methods of diagnosis of conditions associated with abnormal angiogenesis, or determining predisposition thereto. Suitable pharmaceutical compositions are also provided.
    Type: Application
    Filed: August 6, 2018
    Publication date: December 20, 2018
    Inventors: Jennifer Gamble, Mathew Vadas, Gregory Goodall, Jennifer Young
  • THERAPEUTIC AND DIAGNOSTIC MOLECULES
    Publication number: 20160355807
    Abstract: The present invention relates to methods for modulating angiogenesis, comprising administering to a subject, or cells or tissue derived therefrom: (i) one or more miRNA, or precursors or variants thereof, wherein at least one of said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to inhibit angiogenesis; or (ii) one or more antagonists of a miRNA, wherein said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to promote or induce angiogenesis. Also provided are methods of diagnosis of conditions associated with abnormal angiogenesis, or determining predisposition thereto. Suitable pharmaceutical compositions are also provided.
    Type: Application
    Filed: March 22, 2016
    Publication date: December 8, 2016
    Inventors: Jennifer Gamble, Mathew Vadas, Gregory Goodall, Jennifer Young
  • Therapeutic and diagnostic molecules
    Patent number: 9320755
    Abstract: The present invention relates to methods for modulating angiogenesis, comprising administering to a subject, or cells or tissue derived therefrom: (i) one or more miRNA, or precursors or variants thereof, wherein at least one of said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to inhibit angiogenesis; or (ii) one or more antagonists of a miRNA, wherein said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to promote or induce angiogenesis. Also provided are methods of diagnosis of conditions associated with abnormal angiogenesis, or determining predisposition thereto. Suitable pharmaceutical compositions are also provided.
    Type: Grant
    Filed: June 4, 2010
    Date of Patent: April 26, 2016
    Assignees: CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY, UNIVERSITY OF SYDNEY, WENKART FOUNDATION
    Inventors: Jennifer Gamble, Mathew Vadas, Gregory Goodall, Jennifer Young
  • Therapeutic and Diagnostic Molecules
    Publication number: 20120196925
    Abstract: The present invention relates to methods for modulating angiogenesis, comprising administering to a subject, or cells or tissue derived therefrom: (i) one or more miRNA, or precursors or variants thereof, wherein at least one of said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to inhibit angiogenesis; or (ii) one or more antagonists of a miRNA, wherein said miRNA comprises a seed region comprising the sequence UCACAGU (SEQ ID NO:37) to promote or induce angiogenesis. Also provided are methods of diagnosis of conditions associated with abnormal angiogenesis, or determining predisposition thereto. Suitable pharmaceutical compositions are also provided.
    Type: Application
    Filed: June 4, 2010
    Publication date: August 2, 2012
    Applicants: Centenary Institute of Cancer Medicine and Cell Biology, Wenkart Foundation, Medvet Science Pty Ltd., University of Sydney
    Inventors: Jennifer Gamble, Mathew Vadas, Gregory Goodall, Jennifer Young
  • Implantable microscale pressure sensor system for pressure monitoring and management
    Patent number: 6890300
    Abstract: A MEMS chip sensor (10, 20, 30, 40, 50, 60, 70) based upon detection of an induced inductance in the sensor is described. The sensor is used in an environment for detection of fluid pressures. The method and system is particularly used in animals, including humans, to sense pressure changes, particularly pressure in the eyeball.
    Type: Grant
    Filed: August 26, 2003
    Date of Patent: May 10, 2005
    Assignee: Board of Trustees of Michigan State University
    Inventors: John R. Lloyd, Timothy A. Grotjohn, Arthur J. Weber, Frank R. Rosenbaum, Gregory A. Goodall
  • Implantable microscale pressure sensor system for pressure monitoring and management
    Publication number: 20040073137
    Abstract: A MEMS chip sensor (10, 20, 30, 40, 50, 60, 70) based upon detection of an induced inductance in the sensor is described. The sensor is used in an environment for detection of fluid pressures. The method and system is particularly used in animals, including humans, to sense pressure changes, particularly pressure in the eyeball.
    Type: Application
    Filed: August 26, 2003
    Publication date: April 15, 2004
    Applicant: Board of Trustees of Michigan State University
    Inventors: John R. Lloyd, Timothy A. Grotjohn, Arthur J. Weber, Frank Rosenbaum, Gregory A. Goodall